Pharmaceutical compositions comprising the intestinal Lipase inhibitory substances combined with a complex and coordinated dinicotinato Chromium for its use in the treatment and Control of Obesity or overweight

摘要

The present invention relates to the general pharmaceutical industry and the pharmaceutical industry for the production of drugs for the control of obesity and overweight. More specifically, it is composed of a substance that inhibits intestinal fat andO-coordinated chromium diene compounds. Its composition is characterized by a combination or association of a selected intestinal fat inhibitor known as Ortiz and an O-coordinated dinitrobenzene compound known as dinitrobenzochromide.They produce a synergistic product to treat obesity and overweight, with fewer side effects.